Clonidine and Caplyta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Clonidine (clonidine) and Caplyta (lumateperone tosylate). Common drug interactions include palpitations among females and dystonia among males.

The phase IV clinical study analyzes what interactions people have when they take Clonidine and Caplyta. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Caplyta?

Caplyta has active ingredients of lumateperone tosylate. eHealthMe is studying from 3,109 Caplyta users. Check the latest studies of Caplyta.



On Jul, 09, 2026

19 people who take Clonidine and Caplyta together, and have interactions are studied.

Clonidine and Caplyta drug interactions.

What are the common drug interactions of Clonidine and Caplyta, by gender? *:

female:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Fatigue (feeling of tiredness)
  4. Pain
  5. Blood lactic acid increased
  6. Blood pressure diastolic increased
  7. Chest discomfort
  8. Chest pain
  9. Depression
  10. Disturbance in attention

male:

  1. Dystonia (abnormal muscle tone)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Disturbance in attention
  4. Fatigue (feeling of tiredness)
  5. Influenza like illness
  6. Muscular weakness (muscle weakness)
  7. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  8. Obsessive thoughts (intrusive thoughts that produce uneasiness, apprehension, fear, or worry)
  9. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  10. Performance status decreased

What are the common drug interactions of Clonidine and Caplyta, by age (0-1 to 60+)? *:

0-1:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Delusion (a false belief or opinion)
  3. Dissociative disorder
  4. Disturbance in attention
  5. Fatigue (feeling of tiredness)
  6. Influenza like illness
  7. Muscular weakness (muscle weakness)
  8. Obsessive thoughts (intrusive thoughts that produce uneasiness, apprehension, fear, or worry)
  9. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  10. Performance status decreased

2-9:

n/a

10-19:

n/a

20-29:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Bruxism (habitual grinding of the teeth, typically during sleep)
  3. Trichotillomania (the compulsive urge to pull out (and in some cases, eat) one's own hair leading to noticeable hair loss, distress)

30-39:

  1. Palpitations (feelings or sensations that your heart is pounding or racing)
  2. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  3. Blood lactic acid increased
  4. Blood pressure diastolic increased
  5. Burning sensation
  6. Chest discomfort
  7. Chest pain
  8. Depression
  9. Disturbance in attention
  10. Dyspnoea (difficult or laboured respiration)

40-49:

n/a

50-59:

  1. Dry mouth
  2. Fatigue (feeling of tiredness)
  3. Nausea (feeling of having an urge to vomit)
  4. Oedema peripheral (superficial swelling)
  5. Vision blurred
  6. Dystonia (abnormal muscle tone)
  7. Malaise (a feeling of general discomfort or uneasiness)

60+:

  1. Tardive dyskinesia (a disorder that involves involuntary movements)
  2. Dizziness
  3. Fall
  4. Back injury
  5. Head injury
  6. Limb injury
  7. Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  8. Pain

What are the existing conditions these people have? *

  1. Bipolar Disorder (mood disorder): 12 people, 63.16%
  2. Depression: 4 people, 21.05%
  3. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 4 people, 21.05%
  4. Stress And Anxiety: 3 people, 15.79%
  5. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 3 people, 15.79%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.26%
  7. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 5.26%
  8. Blood Pressure Abnormal: 1 person, 5.26%
  9. Constipation: 1 person, 5.26%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and Caplyta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Clonidine and Caplyta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Caplyta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Clonidine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Caplyta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on clonidine and lumateperone tosylate (the active ingredients of Clonidine and Caplyta, respectively), and Clonidine and Caplyta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: